Russell Investments Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-58,141
| Closed | -$8.79M | – | 3031 |
|
|
2022
Q3 | $8.79M | Sell |
58,141
-19,016
| -25% | -$2.87M | 0.02% | 797 |
|
|
2022
Q2 | $11.2M | Sell |
77,157
-31,465
| -29% | -$4.58M | 0.02% | 731 |
|
|
2022
Q1 | $12.9M | Buy |
108,622
+16,150
| +17% | +$1.91M | 0.02% | 723 |
|
|
2021
Q4 | $12.7M | Buy |
92,472
+30,789
| +50% | +$4.24M | 0.02% | 790 |
|
|
2021
Q3 | $8.57M | Buy |
61,683
+7,791
| +14% | +$1.08M | 0.01% | 962 |
|
|
2021
Q2 | $5.23M | Buy |
53,892
+25,103
| +87% | +$2.44M | 0.01% | 1320 |
|
|
2021
Q1 | $1.97M | Sell |
28,789
-17,097
| -37% | -$1.17M | ﹤0.01% | 1882 |
|
|
2020
Q4 | $3.93M | Sell |
45,886
-44,747
| -49% | -$3.83M | 0.01% | 1380 |
|
|
2020
Q3 | $5.89M | Buy |
90,633
+17,182
| +23% | +$1.12M | 0.01% | 1040 |
|
|
2020
Q2 | $5.37M | Buy |
73,451
+5,030
| +7% | +$367K | 0.01% | 1055 |
|
|
2020
Q1 | $2.33M | Buy |
68,421
+30,523
| +81% | +$1.04M | 0.01% | 1382 |
|
|
2019
Q4 | $2.06M | Buy |
37,898
+18,707
| +97% | +$1.02M | ﹤0.01% | 1721 |
|
|
2019
Q3 | $801K | Buy |
+19,191
| New | +$801K | ﹤0.01% | 2112 |
|
|
2019
Q1 | – | Sell |
-12,755
| Closed | -$472K | – | 3138 |
|
|
2018
Q4 | $472K | Buy |
12,755
+258
| +2% | +$9.55K | ﹤0.01% | 2340 |
|
|
2018
Q3 | $469K | Sell |
12,497
-21,306
| -63% | -$800K | ﹤0.01% | 2415 |
|
|
2018
Q2 | $1.34M | Hold |
33,803
| – | – | ﹤0.01% | 1961 |
|
|
2018
Q1 | $871K | Buy |
+33,803
| New | +$871K | ﹤0.01% | 2260 |
|
|
2017
Q3 | – | Sell |
-15,535
| Closed | -$388K | – | 3121 |
|
|
2017
Q2 | $388K | Buy |
+15,535
| New | +$388K | ﹤0.01% | 2508 |
|